Race a factor in mortality in heart attack patients on anti-clotting drug
The first genetic variations linked to race have been identified that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel after a heart attack. In particular, the team found that two DNA variants common in African Americans were associated with an increased risk of both bleeding and death. In Caucasians, a different variant was linked to additional heart attacks and a higher risk of death. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 18, 2014 Category: Science Source Type: news
Promptly Filling Clopidogrel Scrip After PCI Ups Survival Promptly Filling Clopidogrel Scrip After PCI Ups Survival
To prevent stent thrombosis after PCI, new research highlights the importance of filling a prescription for the antiplatelet agent clopidogrel within three days of hospital discharge. Heartwire (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 30, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news
Prescription Delay Following Stent Implantation Is a Common and Deadly Problem (FREE)
By Larry Husten
Edited by Susan Sadoughi, MD , and Lorenzo Di Francesco, MD, FACP, FHM
Patients frequently delay filling prescriptions for clopidogrel after receiving stents, putting themselves at increased risk for death or myocardial infarction in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 29, 2014 Category: Primary Care Source Type: news
Many Delay Blood Thinners After Stent Placement, Risking Death
Going 3 days without Plavix triples odds of heart attack within a month, researchers say (Source: WebMD Health)
Source: WebMD Health - May 28, 2014 Category: Consumer Health News Source Type: news
Antiplatelet Drug Delay Hikes Stent Death Risk
(MedPage Today) -- Nearly one in three patients in a Canadian province failed to fill prescriptions for clopidogrel in the days after receiving a coronary stent, and over the next month these patients suffered heart attacks at three times the rate and died at five times the rate of patients who promptly filled their prescriptions for the drug, researchers reported. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 28, 2014 Category: Cardiology Source Type: news
Many Delay Blood Thinners After Stent Placement, Risking Death
Going 3 days without Plavix triples odds of heart attack within a month, researchers say
Source: HealthDay
Related MedlinePlus Pages: Angioplasty, Blood Thinners (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 28, 2014 Category: Consumer Health News Source Type: news
Prescription Delay Following Stent Implantation Is a Common and Deadly Problem
After receiving a stent, many patients delay or fail to fill their prescription for clopidogrel or another antiplatelet agent. Now, a study published in the Journal of the American Heart Association offers evidence that this problem is widespread and often leads to serious consequences. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 28, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
Post procedure clopidogrel cuts amputation rates
Read the full story on MD Consult:
Post procedure clopidogrel cuts amputation rates (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - April 2, 2014 Category: Journals (General) Source Type: news
A New Novartis Heart Failure Drug Might Be A Blockbuster
I try to avoid using words like "blockbuster" and "breakthrough" when writing about new drugs and treatments. I've been disappointed too many times. But, though they've been in short supply lately in cardiovascular medicine, sometimes there really are breakthroughs and blockbusters. In my career writing about cardiovascular medicine I've seen the introduction of the ACE inhibitors, statins, stents, ICDs, and clopidogrel, among others. All of these became multibillion-dollar products and, more importantly, vastly improved the prospects for millions of people with cardiovascular disease. Now there's a new candidate tha...
Source: Forbes.com Healthcare News - April 1, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news
Hawaii Files Plavix Lawsuit Against BMS And Sanofi
Hawaii Attorney General David Louie has filed a lawsuit against the manufacturers and distributors of prescription drug blood thinner Plavix. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - March 21, 2014 Category: Pharmaceuticals Source Type: news
Genotype-Guided Drug Therapy in CardiologyGenotype-Guided Drug Therapy in Cardiology
From clopidogrel to warfarin and statins, genotyping can affect drug metabolism but should genetics guide pharmacotherapy? Drs. Harrington, Ohman, Mega, and Robinson have a spirited discussion. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 6, 2014 Category: Cardiology Tags: Cardiology Roundtable Source Type: news
Cardio Notes: Morphine Weakens Clopidogrel
(MedPage Today) -- The recommended pain medication for patients with myocardial infarction may interfere with clopidogrel, and a new effort targets readmissions. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 9, 2013 Category: Cardiology Source Type: news
Morphine, Blood Thinner Plavix a Bad Mix for Heart Attack Victims: Study
Title: Morphine, Blood Thinner Plavix a Bad Mix for Heart Attack Victims: StudyCategory: Health NewsCreated: 12/4/2013 4:36:00 PMLast Editorial Review: 12/5/2013 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - December 5, 2013 Category: Cardiology Source Type: news
Morphine, Blood Thinner Plavix a Bad Mix for Heart Attack Victims
Painkiller appeared to slow, diminish anti-clotting effect of heart drug
Source: HealthDay
Related MedlinePlus Pages: Blood Thinners, Drug Reactions, Pain Relievers (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 4, 2013 Category: Consumer Health News Source Type: news
PCI No Riskier With Plavix Plus Statins, CCBs (CME/CE)
(MedPage Today) -- Patients undergoing percutaneous coronary intervention did not have an increased risk of cardiovascular events if they received clopidogrel against a background of statin or calcium channel blocker therapy, a large clinical trial showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 18, 2013 Category: Cardiology Source Type: news
